The trajectory of Viagra presents a interesting case for investors in the medicinal sector. While initially a tremendous success, generating huge profits, the patent end and the subsequent arrival of cheaper alternatives have drastically changed income. This presents questions about the future viability of analogous drug innovations and suggests… Read More